Drug Information

Drug General Information
Drug ID
D0G2CY
Former ID
DNC009204
Drug Name
(+/-)-3-allylazetidin-2-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529529]
Formula
C6H9NO
Canonical SMILES
C=CCC1CNC1=O
InChI
1S/C6H9NO/c1-2-3-5-4-7-6(5)8/h2,5H,1,3-4H2,(H,7,8)
InChIKey
XWLCLNCCEDQVSS-UHFFFAOYSA-N
PubChem Compound ID
20449950
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529529]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529529Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. Epub 2008 May 24.3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.
Ref 529529Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. Epub 2008 May 24.3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.